All-in-one bacmids

An efficient reverse genetics strategy for influenza a virus vaccines

Hongjun Chen, Matthew Angel, Weizhong Li, Courtney Finch, Ana Silvia Gonzalez, Troy Sutton, Jefferson Santos, Daniel R. Perez

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Vaccination is the first line of defense against influenza virus infection, yet influenza vaccine production methods are slow, antiquated, and expensive as a means to effectively reduce the virus burden during epidemic or pandemic periods. There is a great need for alternative influenza vaccines and vaccination methods with a global scale of impact. We demonstrate here a strategy to generate influenza A virus in vivo by using bacmid DNAs. Compared to the classical reverse genetics system, the "eight-in-one" bacmids (bcmd-RGFlu) showed higher efficiency of virus rescue in various cell types. Using a transfection-based inoculation (TBI) system, intranasal delivery to DBA/2J and BALB/c mice of bcmd-RGFlu plus 293T cells led to the generation of lethal PR8 virus in vivo. A prime-boost intranasal vaccination strategy using TBI in the context of a bcmd-RGFlu carrying a temperaturesensitive H1N1 virus resulted in protection of mice against lethal challenge with the PR8 strain. Taken together, these studies provide proof of principle to highlight the potential of vaccination against influenza virus by using in vivo reverse genetics. Importance: Vaccination is the first line of defense against influenza virus infections. A major drawback in the preparation of influenza vaccines is that production relies on a heavily time-consuming process of growing the viruses in eggs. We propose a radical change in the way influenza vaccination is approached, in which a recombinant bacmid, a shuttle vector that can be propagated in both Escherichia coli and insect cells, carries an influenza virus infectious clone (bcmd-RGFlu). Using a surrogate cell system, we found that intranasal delivery of bcmd-RGFlu resulted in generation of influenza virus in mice. Furthermore, mice vaccinated with this system were protected against lethal influenza virus challenge. The study serves as a proof of principle of a potentially universal vaccine platform against influenza virus and other pathogens.

Original languageEnglish (US)
Pages (from-to)10013-10025
Number of pages13
JournalJournal of virology
Volume88
Issue number17
DOIs
StatePublished - Jan 1 2014

Fingerprint

Reverse Genetics
Influenza Vaccines
Orthomyxoviridae
vaccination
Vaccination
vaccines
influenza
Viruses
lethal genes
Virus Diseases
mice
transfection
Transfection
Influenza A virus
viruses
H1N1 Subtype Influenza A Virus
Genetic Vectors
cells
genetic vectors
HEK293 Cells

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Chen, H., Angel, M., Li, W., Finch, C., Gonzalez, A. S., Sutton, T., ... Perez, D. R. (2014). All-in-one bacmids: An efficient reverse genetics strategy for influenza a virus vaccines. Journal of virology, 88(17), 10013-10025. https://doi.org/10.1128/JVI.01468-14
Chen, Hongjun ; Angel, Matthew ; Li, Weizhong ; Finch, Courtney ; Gonzalez, Ana Silvia ; Sutton, Troy ; Santos, Jefferson ; Perez, Daniel R. / All-in-one bacmids : An efficient reverse genetics strategy for influenza a virus vaccines. In: Journal of virology. 2014 ; Vol. 88, No. 17. pp. 10013-10025.
@article{7710d43077044098b3bd2a786413b346,
title = "All-in-one bacmids: An efficient reverse genetics strategy for influenza a virus vaccines",
abstract = "Vaccination is the first line of defense against influenza virus infection, yet influenza vaccine production methods are slow, antiquated, and expensive as a means to effectively reduce the virus burden during epidemic or pandemic periods. There is a great need for alternative influenza vaccines and vaccination methods with a global scale of impact. We demonstrate here a strategy to generate influenza A virus in vivo by using bacmid DNAs. Compared to the classical reverse genetics system, the {"}eight-in-one{"} bacmids (bcmd-RGFlu) showed higher efficiency of virus rescue in various cell types. Using a transfection-based inoculation (TBI) system, intranasal delivery to DBA/2J and BALB/c mice of bcmd-RGFlu plus 293T cells led to the generation of lethal PR8 virus in vivo. A prime-boost intranasal vaccination strategy using TBI in the context of a bcmd-RGFlu carrying a temperaturesensitive H1N1 virus resulted in protection of mice against lethal challenge with the PR8 strain. Taken together, these studies provide proof of principle to highlight the potential of vaccination against influenza virus by using in vivo reverse genetics. Importance: Vaccination is the first line of defense against influenza virus infections. A major drawback in the preparation of influenza vaccines is that production relies on a heavily time-consuming process of growing the viruses in eggs. We propose a radical change in the way influenza vaccination is approached, in which a recombinant bacmid, a shuttle vector that can be propagated in both Escherichia coli and insect cells, carries an influenza virus infectious clone (bcmd-RGFlu). Using a surrogate cell system, we found that intranasal delivery of bcmd-RGFlu resulted in generation of influenza virus in mice. Furthermore, mice vaccinated with this system were protected against lethal influenza virus challenge. The study serves as a proof of principle of a potentially universal vaccine platform against influenza virus and other pathogens.",
author = "Hongjun Chen and Matthew Angel and Weizhong Li and Courtney Finch and Gonzalez, {Ana Silvia} and Troy Sutton and Jefferson Santos and Perez, {Daniel R.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1128/JVI.01468-14",
language = "English (US)",
volume = "88",
pages = "10013--10025",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "17",

}

Chen, H, Angel, M, Li, W, Finch, C, Gonzalez, AS, Sutton, T, Santos, J & Perez, DR 2014, 'All-in-one bacmids: An efficient reverse genetics strategy for influenza a virus vaccines', Journal of virology, vol. 88, no. 17, pp. 10013-10025. https://doi.org/10.1128/JVI.01468-14

All-in-one bacmids : An efficient reverse genetics strategy for influenza a virus vaccines. / Chen, Hongjun; Angel, Matthew; Li, Weizhong; Finch, Courtney; Gonzalez, Ana Silvia; Sutton, Troy; Santos, Jefferson; Perez, Daniel R.

In: Journal of virology, Vol. 88, No. 17, 01.01.2014, p. 10013-10025.

Research output: Contribution to journalArticle

TY - JOUR

T1 - All-in-one bacmids

T2 - An efficient reverse genetics strategy for influenza a virus vaccines

AU - Chen, Hongjun

AU - Angel, Matthew

AU - Li, Weizhong

AU - Finch, Courtney

AU - Gonzalez, Ana Silvia

AU - Sutton, Troy

AU - Santos, Jefferson

AU - Perez, Daniel R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Vaccination is the first line of defense against influenza virus infection, yet influenza vaccine production methods are slow, antiquated, and expensive as a means to effectively reduce the virus burden during epidemic or pandemic periods. There is a great need for alternative influenza vaccines and vaccination methods with a global scale of impact. We demonstrate here a strategy to generate influenza A virus in vivo by using bacmid DNAs. Compared to the classical reverse genetics system, the "eight-in-one" bacmids (bcmd-RGFlu) showed higher efficiency of virus rescue in various cell types. Using a transfection-based inoculation (TBI) system, intranasal delivery to DBA/2J and BALB/c mice of bcmd-RGFlu plus 293T cells led to the generation of lethal PR8 virus in vivo. A prime-boost intranasal vaccination strategy using TBI in the context of a bcmd-RGFlu carrying a temperaturesensitive H1N1 virus resulted in protection of mice against lethal challenge with the PR8 strain. Taken together, these studies provide proof of principle to highlight the potential of vaccination against influenza virus by using in vivo reverse genetics. Importance: Vaccination is the first line of defense against influenza virus infections. A major drawback in the preparation of influenza vaccines is that production relies on a heavily time-consuming process of growing the viruses in eggs. We propose a radical change in the way influenza vaccination is approached, in which a recombinant bacmid, a shuttle vector that can be propagated in both Escherichia coli and insect cells, carries an influenza virus infectious clone (bcmd-RGFlu). Using a surrogate cell system, we found that intranasal delivery of bcmd-RGFlu resulted in generation of influenza virus in mice. Furthermore, mice vaccinated with this system were protected against lethal influenza virus challenge. The study serves as a proof of principle of a potentially universal vaccine platform against influenza virus and other pathogens.

AB - Vaccination is the first line of defense against influenza virus infection, yet influenza vaccine production methods are slow, antiquated, and expensive as a means to effectively reduce the virus burden during epidemic or pandemic periods. There is a great need for alternative influenza vaccines and vaccination methods with a global scale of impact. We demonstrate here a strategy to generate influenza A virus in vivo by using bacmid DNAs. Compared to the classical reverse genetics system, the "eight-in-one" bacmids (bcmd-RGFlu) showed higher efficiency of virus rescue in various cell types. Using a transfection-based inoculation (TBI) system, intranasal delivery to DBA/2J and BALB/c mice of bcmd-RGFlu plus 293T cells led to the generation of lethal PR8 virus in vivo. A prime-boost intranasal vaccination strategy using TBI in the context of a bcmd-RGFlu carrying a temperaturesensitive H1N1 virus resulted in protection of mice against lethal challenge with the PR8 strain. Taken together, these studies provide proof of principle to highlight the potential of vaccination against influenza virus by using in vivo reverse genetics. Importance: Vaccination is the first line of defense against influenza virus infections. A major drawback in the preparation of influenza vaccines is that production relies on a heavily time-consuming process of growing the viruses in eggs. We propose a radical change in the way influenza vaccination is approached, in which a recombinant bacmid, a shuttle vector that can be propagated in both Escherichia coli and insect cells, carries an influenza virus infectious clone (bcmd-RGFlu). Using a surrogate cell system, we found that intranasal delivery of bcmd-RGFlu resulted in generation of influenza virus in mice. Furthermore, mice vaccinated with this system were protected against lethal influenza virus challenge. The study serves as a proof of principle of a potentially universal vaccine platform against influenza virus and other pathogens.

UR - http://www.scopus.com/inward/record.url?scp=84912091592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912091592&partnerID=8YFLogxK

U2 - 10.1128/JVI.01468-14

DO - 10.1128/JVI.01468-14

M3 - Article

VL - 88

SP - 10013

EP - 10025

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 17

ER -